activation system. The test compound was always added to cultures at least 1 min prior to addition of bleomycin as this schedule appeared to enhance the intercalation is necessary but not sufficient for frameshift amplification response. Treatment was followed by removal of the drug(s) mutagenesis since bleomycin amplifiers lacking frameand addition of fresh medium containing 3 µg/ml cytochalasin B for~16 h.
Introduction
and coverslipped. Slides were examined for numbers of binucleate and mononucleate cells in order to assess the antiproliferative effect of the drug Frequently, compounds not expected to be genotoxic on the treatment. In addition~300-500 binucleate cells were examined for the basis of structure produce unexpected genotoxicity in standard presence of micronuclei indicative of chromosome breakage.
Test compounds were evaluated at concentrations up to the limits of genetic toxicology assays. The underlying molecular bases for solubility and/or toxicity. For chemicals testing positive as amplifiers, an such responses are often not understood and, therefore, rational approximate least effective concentration was determined. Enhancement of synthesis to decrease or eliminate genotoxicity cannot be bleomycin-induced micronucleus formation is interpreted as indicating that carried out. We have proposed that some unexpected genothe test article interacted with DNA in such a way as to enhance accessibility toxicities arise from non-covalent drug-DNA interactions, of the DNA to bleomycin. An arbitrary 2-fold rule was applied as a minimal requirement for a positive amplification response (Snyder and Strekowski, particularly intercalation, and we have recently developed a 1999). Additional testing will help to further define appropriate criteria for a
Chinese hamster V79 cell-based assay system for detecting positive response in this assay.
such events (Snyder, 1998; Snyder and Strekowski, 1999) .
Ames bacterial reversion assays
The assay is a modification of a naked DNA system in which Ames Salmonella mutagenesis assays were conducted in frameshift strains the ability of putative DNA intercalating agents to amplify TA-1538, TA-98 and/or TA-1537 and in some cases in the non-frameshift bleomycin-induced DNA strand breakage was assessed (for strain TA-100 essentially according to standard procedures. An Aroclora review see Strekowski, 1992 ). In the cell-based assay, induced rat liver S9 fraction was obtained from Moltox. Positive responses were defined as at least 2-fold increases over background colony counts for bleomycin-dependent DNA damage is quantified using TA-98 and TA-100 and at least 3-fold increases over background for TA-1535 micronucleus formation as the end-point. We have conducted and TA-1538.
bleomycin amplification studies with a wide range of structural classes of known intercalating and non-intercalating Results and discussion compounds (Snyder and Strekowski, 1999) . In some cases intercalative ability has been confirmed with the ethidium Figure 1 shows the chemical structures of the series 1 compounds used in the present studies. As shown in Table I , displacement assay (Snyder, 1998) or viscometry (Snyder and Strekowski, 1999) . However, since DNA intercalation is only the naphthylpropenoic acid derivatives 1 and 5, the benzoxazole 3 and the phenylpyridazine 7 tested negative in Ames one way in which bleomycin amplification can occur (Snyder and Strekowski, 1999) , additional studies are essential in order frameshift strains, whereas the naphthylpropenoic acid derivatives 2 and 6, the benzthiazole 4, the phenylpyridazine 8 and to further demonstrate the link between intercalation and bleomycin amplification. the quinoxaline 9 were positive frameshift mutagens. None of these compounds were positive in Ames base pair strains (not To better address this, we examined the bleomycin amplification responses of two series of proprietary compounds for shown). Compounds 2, 4, 8 and 9 required Aroclor-induced S9 mix for mutagenicity, whereas compound 6 was equally which Ames frameshift mutagenesis data are available. Because
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Thus for series 1 compounds, frameshift mutagenicity and bleomycin amplification results are consistent with designation of these compounds as DNA intercalating agents even though the intercalative structure-activity relationship (SAR) of members of this series is not obvious.
The proprietary nature of series 2 compounds precludes publication of their structures. All 18 compounds are structurally related heterocyclic aromatic amines comprised of two fused rings and two or three unfused rings. A clear SAR for Ames frameshift mutagenicity was determined and found to relate to a particular ring system. The compounds reported herein comprise six frameshift-positive compounds, i.e. 1, 2, 3, 7, 10 and 12, and 12 frameshift-negative compounds (Table  II) . Compound 14 was positive in the base pair strain TA-100, but was not a frameshift mutagen. As would be expected for aromatic amines, these compounds were only mutagenic in the presence of an S9 metabolic activation system.
Using an arbitrary 2-fold criterion for a positive amplification response (Snyder and Strekowski, 1999) , only four series 2 compounds, i.e. 4, 14, 15 and 18, are considered to lack intercalation activity. None of these four were frameshift mutagens. Compound 4 had limited solubility; compound 14 had a somewhat different ring configuration and compound 18 was a member of a structurally dissimilar class of compounds. Compound 15 was very similar in structure to compound 6, which produced only a very weak bleomycin amplification response. Of the remaining 14 amplifying compounds, six were frameshift mutagens and the other eight were not. All six of the mutagens carried a cationic N-alkyl substitution, whereas this function was not found in any of the intercalating but non-mutagenic compounds. This apparent requirement for a cationic terminus on an intercalating agent in order to confer genotoxicity was also previously observed for antihistamines (Snyder, 1998) . The cationic function may mutagenic with or without activation. The Ames-positive serve to stabilize intercalative binding, prolonging the residence compounds all have in common a potentially reactive amine, time of the molecule on the DNA and, in this way, enhancing while this function is lacking in all Ames-negative compounds genotoxic potential. Thus within the antihistamine series and with the exception of compound 5. Cytochrome p450-driven both chemical series reported herein, it may be concluded that metabolism of compounds 2, 4, 8 and 9 is expected to generate intercalation is necessary but not sufficient for genotoxicity. DNA-reactive hydroxylamines. Compound 6 is already a Frameshift mutagenesis is generally thought to arise via reactive molecule and needs no further metabolism for mutaintercalation yet the fact that series 2 compounds are genicity. None of these compounds tested positive in the aromatic amines and that metabolic activation is required in vitro micronucleus assay in the absence of bleomycin for mutagenesis leads to the question of the actual role of (not shown).
intercalation in frameshift mutagenesis within this series. The Table I demonstrates that with the exception of compound intercalative ability of these compounds could conceivably be 4, positive Ames frameshift mutagens are intercalators enhanced by P450-driven metabolic activation, but this seems (bleomycin amplification positive) and negative Ames unlikely since intercalation is primarily a function of planarity. frameshift compounds are not intercalators (bleomycin ampliIf intercalation simply served the function of bringing a fication negative). Compound 4, despite testing positive in the DNA-reactive group (e.g. an activated amine) into stabilized Ames system, did not appear to intercalate in V79 cells. The proximity with the DNA, one would expect these compounds reason for this is not clear but may relate to poor cellular to also be base pair mutagens, but for the most part they are not. uptake since no antiproliferative effects of this compound were Studies on heterocyclic aromatic amines in the aminofluorene noted when tested alone in V79 cells (not shown). It may also (Hoffman and Fuchs, 1997) and aminoimidazoazaarene relate to the absence of S9 in the amplification assay although (Schut and Snyderwine, 1999) series suggest that frameshift it seems unlikely that the S9 fraction would substantially mutagenesis occurs when covalent adduct formation stabilizes modify the intercalating ability of this compound. The structural Streisinger 'slips' at repetitive base sites (Streisinger and similarity between compounds 2 and 5, in the light of their Owen, 1985) . This may be a common feature behind all opposing mutagenicities, is interesting. The fact that compound frameshift mutagenesis since even classical intercalators such 2 intercalates based on amplification results, while compound as acridines appear to act through stabilization of slipped 5 does not, may provide the explanation for these results. For structures (Ferguson and Denny, 1990 ). Thus any adduct or this entire series, prediction of intercalation based on structure helical distortion that tends to disproportionately favor the alone would be difficult as there is no obvious relationship slipped state might be expected to promote frameshift mutabetween the rather subtle structural variations and intercalation/ frameshift mutagenesis.
genesis. In the absence of such detectable 'slips', mutagenesis
Frameshift mutagenesis and DNA intercalation would be expected to arise from traditional adducted base
